Vladimir Putin operates a program for which the Russian government enrolled 17,954 billion rubles between 2027 and 2029. Money is intended to finance fresh drugs, biotechnology, investigation on cell aging and active longevity. For Poland it is simply a signal that the Kremlin treats medicine of the future as a tool of the power of the state.
Almost 18 billion rubles in 3 years
The Russian budget task foresees 5.73 billion rubles for the National Programme "New wellness Technologies" in 2027, 6.50 billion in 2028 and another 5.73 billion in 2029. Together, that's 17.954 billion rubles. Such amounts were given by the ‘Commeersant’ on the basis of budgetary documents.
You gotta separate the fact from the catchy headline. The authoritative program does not bear the name ‘Putin's longevity’ and does not service only 1 man. It includes the improvement of medicines, medical devices, regenerative medicine and prevention. However, investigation into extending active life is an open part of it, and backing grows as another Russian wellness programs await cuts. That says a lot about the Kremlin hierarchy.
Ageing of cells, bioprints and organs from pigs
The Russian Ministry of discipline and Higher Education describes 2 pillars of the project: “Biological and cognitive technologies of the future” and regenerative medicine and technologies of healthy longevity. The authoritative list of studies includes cellular ageing, bioprinting and methods to reduce graft rejection. In 2025 21 investigation projects were planned under the first of these pillars.
"The Wall Street Journal" described a Russian initiative as an undertaking supported by people from the immediate vicinity of the President. Among the central figures was Maria Woroncowa, daughter of Putin and endocrinologist, and Mikhail Kowalczuk, manager of the Kurczat Institute. investigation plans include printing live tissues, gene therapy, cryotherapy and xenotransplantation, i.e. human transplantation of animal organs.
It's not pure fantasy. Xenotransplantation is already at the phase of first experimental applications, and U.S. Food and Drug Agency describes pig tissue and organ transplants as a developed medical direction. However, the road to regular replacement of human organs remains far away. Bioprinting of whole, efficient organs is inactive measured by vascular problems, tissue maturity, discard and safety. present there is no technology for immortality.
Putin talked about life for 150 years
The interest of the Russian leader is not based solely on anonymous accounts. During their visit to Beijing in September 2025, microphones recorded Putin's conversation with Xi Jinping about biotechnology, organ transplants and the anticipation of extending human life to up to 150 years. Putin was born in 1952. In October 2026, he turns 74, just as a large part of his political environment belongs to a generation facing the problem of succession.
Here discipline meets the nature of the Russian system. Authoritarian power personalizes the state, so the wellness of the leader becomes a systemic issue. The talks with Putin stay part of the policy over the heads of our region, and the biological durability of the Kremlian elite may besides prolong the durability of its imperial course.
Russian technology matters to Poland
Poland should not laughter at the reports of Putin's "immortality". The ridicule of propaganda is justified, but ignoring the investigation facilities would be a mistake. Gene technologies, regenerative medicine and bioprint are utilized in civil, military and economical applications. A country that gains the advantage in these areas will gain patents, staff and resilience of the wellness system.
In parallel, Russia devotes tremendous resources to the war and develops tools of force towards its neighbours. so Polish safety requires the protection of its own manufacture and technological facilities. It is not adequate to observe Russian laboratories with an ironic smile. Poland needs its own biomedical programs, control of strategical genetic data and conditions that will halt researchers in the country.
The Kremlin wraps the task in public wellness language, and the media see it as a pursuit of the old elite in favour of extending its own reign. Both paintings may contain part of the truth. What matters to us is concrete: Russia finances technologies, which may be strategical in a fewer or respective years. Poland must build its own advantage, alternatively of being satisfied with the function of the recipient of another people's inventions.
Sources: ‘Kommersant’, Ministry of discipline and Higher Education of the Russian Federation, ‘The Wall Street Journal’, American Food and Drug Agency.
